[1] |
Cao XB, Wu ZY. Methadone maintenance treatment as an HIV prevention strategy: a research update. China J STD/AIDS, 2011; 17, 196−9. (In Chinese |
[2] |
Cao XB, Lin CQ, Wang CH, et al. The national methadone maintenance treatment program. In: Wu ZY, Wang Y, Detels R, et al. HIV/AIDS in China. Springer, 2020; 177−200. |
[3] |
WHO, UNODC, UNAIDS. WHO/UNODC/UNAIDS Position Paper: Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention. Geneva: WHO, 2004. |
[4] |
Cao XB, Wu ZY, Rou KM, et al. Retention and its predictors among methadone maintenance treatment clients in China: a six-year cohort study. Drug Alcohol Depend, 2014; 145, 87−93. doi: 10.1016/j.drugalcdep.2014.09.776 |
[5] |
Xu JS, Huan XP, Yang HT, et al. Survey on drug abuse among patients on methadone maintenance treatment in Jiangsu Province. Chin J Drug Depend, 2009; 18, 424−7. (In Chinese |
[6] |
Peles E, Adelson M, Schreiber S. Benzodiazepine usage during 19.5 years in methadone maintenance treatment patients and its relation to long-term outcome. Isr J Psychiatry Relat Sci, 2014; 51, 285−8. |
[7] |
Brands B, Blake J, Marsh DC, et al. The impact of benzodiazepine use on methadone maintenance treatment outcomes. J Addict Dis, 2008; 27, 37−48. |
[8] |
Mark TL, Dilonardo J, Vandivort R, et al. Psychiatric and medical comorbidities, associated pain, and health care utilization of patients prescribed buprenorphine. J Subst Abuse Treat, 2013; 44, 481−7. doi: 10.1016/j.jsat.2012.11.004 |
[9] |
White WL, Campbell MD, Spencer RD, et al. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention. J Psychoactive Drugs, 2014; 46, 114−22. doi: 10.1080/02791072.2014.901587 |
[10] |
Herdener M, Dürsteler KM, Seifritz E, et al. Changes in substance use in patients receiving opioid substitution therapy and resulting clinical challenges: a 17-year treatment case register analysis. Lancet Psychiatry, 2017; 4, 302−9. doi: 10.1016/S2215-0366(17)30080-9 |